페서리 시장 : 점유율 분석, 산업 동향 및 통계, 성장 예측(2024-2029년)

The pessary market is projected to grow with a CAGR of 8.87% during the forecast period.

The COVID-19 pandemic has had a substantial impact on the growth of the pessary market owing to the significant decline in manufacturing processes, restricted demand and supply, and restricted hospital visits to avoid contact with infectious people. The industry has witnessed a negative impact as most of the population defer prosthetic surgeries due to transportation restrictions and the fear of viral infection. This has also resulted in the postponement of procedures, which included vaginal insertion of pessary as well. However, with the resumed services and prosthetic procedures, the demand for pessaries for treating various pelvic floor disorders has increased, thus the studied market has witnessed significant growth and is expected to grow over the forecast period.

Factors such as the increasing prevalence of pelvic organ prolapse, urinary incontinence in patients, increasing adoption of non-invasive treatment options, changing women's lifestyles, and a rise in the geriatric population are boosting the growth of the pessary market.

The prevalence of urinary incontinence (UI) is higher in women and elderly patients and creates a negative impact on their quality of life, which is the key factor driving the growth of the market. Urinary incontinence is becoming more common among people due to aging-related changes in the lower urinary system, including decreased bladder capacity and fullness sensation, decreased detrusor muscle contraction rate, decreased pelvic floor muscle resistance, and increased residual urine volume. For instance, according to an article published in the National Library of Medicine (NLM), in August 2022, an estimated 423 million people experience some form of UI worldwide. Similarly, according to an article published in Scientific Reports, in October 2022, it has been observed that the risk of UI increases with the first birth age, greater than 32, and decreases if the first birth occurs before age 32. Also, as per the same source, the prevalence of UI ranges between 5% to 70% during pregnancy and the postnatal period. Thus, the high prevalence of UI increases the demand for pessaries, thereby increasing the market's growth.

In addition, the increasing incidences of pelvic organ prolapse in females contribute to the pessary market's growth. The incidences of pelvic organ prolapse increase with age and after multiple pregnancies. According to an article published in Scientific Reports, in June 2022, pelvic floor disorders (PFD) which include UI, pelvic organ prolapse (POP), and bowel dysfunction (difficult defecation and anal incontinence (AI)) are common among adult women seeing in primary care settings. It has been observed that bowel dysfunction was the most prevalent PFD among women, accounting for 24.6% of all cases, followed by urine incontinence (11.1%) and pelvic organ prolapse (POP) (4.4%) in Iowa. Additionally, as per the same source, about 1.1% had all three categories of PFD, and 5.5% had precisely two PFD. Thus, the high prevalence of pelvic organ prolapse in women increases the demand for pessaries to treat pelvic organ prolapse issues in women, thereby contributing to the market growth.

Therefore, owing to the aforementioned factors, such as the high burden of urinary incontinence and pelvic organ prolapse, the studied market is anticipated to grow over the forecast period. However, patient discomfort and fear of side effects are some factors that hinder the market's growth.

Pessary Market Trends

Ring Pessary Segment Expects to Register a Significant CAGR Over the Forecast Period

The ring pessary segment is expected to witness significant growth over the forecast period owing to the factors such as ease of usage and patient comfort and is appropriate for all stages of pelvic organ prolapse and urinary incontinence as well as for the prevention of infectious diseases. Ring pessaries are transvaginally implanted devices that stabilize and support the urethra and bladder neck, lengthen the urethra, and provide moderate compression of the urethra against the pubic bone during a rise in intra-abdominal pressure. In addition to its use in women with stress urinary incontinence, a continence ring pessary may help certain women who experience urine urgency and frequency due to pelvic organ prolapse pressure.

The high prevalence of urinary incontinence and pelvic organ prolapse increases the demand for pessaries. For instance, according to an article published in the International Urogynaecology Journal, in November 2021, it has been observed that about 40% of women experience pelvic floor dysfunction or pelvic organ prolapse (POP), and pessary treatment is one therapy option that has a high level of patient satisfaction (75.3%), efficacy (90.7%) and a positive impact on the improvement of vaginal and sexual symptoms, quality of life, and mental health. In addition, as per the same source, the ring pessary without a membrane is the most frequently used type that allows for sexual activity while retaining less vaginal discharge than occlusive (Gellhorn) varieties or devices with a membrane. This increases their adoption among the users hence propelling the segment's growth.

Moreover, the rising approvals for pessaries to treat pelvic organ prolapse are likely to contribute to the market growth. For instance, in January 2021, WHO recommended a dapivirine vaginal ring (DPV-VR) that may offer an additional prevention choice for women at substantial risk of HIV infection as part of combination prevention approaches. Also, the Food and Drug Administration (FDA) has approved ProVate (ConTIPI), a vaginal ring pessary with a disposable applicator for the temporary, nonsurgical management of pelvic organ prolapse in women.

Hence, due to the aforementioned factors, the segment is anticipated to grow at a significant growth over the forecast period.

North America is Expected to Have the Significant Market Share Over the Forecast Period

North America is anticipated to have a significant market share owing to the factors such as the aging female population, lifestyle changes that cause hormonal disruptions, the rising prevalence of pelvic organ prolapse and urinary incontinence, increased health awareness, and the presence of major players.

The increasing prevalence of urinary incontinence and pelvic organ prolapse are the major factor driving the growth of the pessary market in the region. For instance, according to an article published by the National Center for Biotechnology Information (NCBI), in October 2022, due to advancing age, approximately 9.7% of women between the ages of 20 and 39 and 49.7% of women over the age of 80 are likely to experience pelvic organ prolapse during their lives. As per the same source, by 2050, the number of people with pelvic organ prolapse is expected to rise by 59%. Similarly, according to an article published in the NCBI, in August 2021, it has been observed that urinary incontinence affects women disproportionately more than males and it significantly increases among women aged 60 years and older.

Additionally, the aging, overweight, and obese population of the United States is expected to add to the burden and expense of PFD on society and the healthcare system. For instance, according to an article published in Scientific Reports, in June 2022, about 1 in 2 adults is expected to be obese, and nearly 1 in 4 adults are projected to have severe obesity by 2030 in the United States. Thus, the increase in the obese population increases the risk of developing a range of urinary, bowel, and sexual dysfunction problems as well as uterovaginal prolapse, hence propelling the demand for pessaries over the forecast period.

Moreover, the increasing focus of the market players on developing treatment and non-invasive medical devices for treating pelvic floor diseases is also contributing to the market's growth. For instance, in June 2021, Femtherapeutics Inc. was developing a custom-made pessary, a device that combined artificial intelligence-driven machine learning and 3D design to relieve urine incontinence and discomfort in women with pelvic organ prolapse.

Thus, the increasing incidences of pelvic floor disorders, the increasing number of women's aging population, and the rising focus of players to develop non-invasive medical devices for treatment are expected to propel the market's growth in the region over the forecast period.

Pessary Industry Overview

The pessary market is highly competitive with a huge number of domestic as well as international players. New product development, mergers, acquisitions, partnerships, and collaboration are some of the primary strategic activities undertaken by market players to withhold their positions. Some of the key players are CooperSurgical Inc., MedGyn Products Inc., Panpac Medical Corporation, Integra Lifesciences, and Dr. Arabin GmbH & Co. KG.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Prevalence of Pelvic Organ Prolapse, Urinary Incontinence and Rise in Geriatric Population
  • 4.2.2 Increasing Adoption of Non-Invasive Treatement Options
  • 4.2.3 Rising Concern for Women's Health and Government Initiatives
• 4.3 Market Restraints
  • 4.3.1 Patient Discomfort and Fear of Side Effects
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

• 5.1 By Type
  • 5.1.1 Gellhorn
  • 5.1.2 Ring
  • 5.1.3 Donut
  • 5.1.4 Others
• 5.2 By End User
  • 5.2.1 Hospital Pharmacies
  • 5.2.2 Retail Pharmacies
  • 5.2.3 Online Pharmacies
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 CooperSurgical Inc.
  • 6.1.2 Artisan Medical
  • 6.1.3 MedGyn
  • 6.1.4 Panpac Medical Corporation
  • 6.1.5 Bioteque America
  • 6.1.6 Personal Medical Corporation
  • 6.1.7 Dr. Arabin GmbH & Co. KG
  • 6.1.8 Integra Lifesciences
  • 6.1.9 Bray Group Limited
  • 6.1.10 Thomas Medical
  • 6.1.11 Bliss GVS Pharma Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS